{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:07:07Z","timestamp":1789589227389,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Br. J. Biomed. Sci."],"abstract":"<jats:p>\n                    Chronic inflammatory skin conditions such as psoriasis, eczema, and acne are driven by sustained inflammation, oxidative stress, and impaired tissue repair. Current treatments often lead to adverse effects with prolonged use highlighting the need for safer, targeted alternatives. Withaferin-A, a bioactive compound derived from\n                    <jats:italic>Withania somnifera<\/jats:italic>\n                    , has demonstrated potent anti-inflammatory and antioxidant properties in various disease models. This study explored the potential of Withaferin-A liposome-loaded gels for topical delivery, testing their efficacy in an inflamed skin model. Withaferin-A liposomes were prepared using the ethanol injection method and incorporated into hydroxypropyl methylcellulose (HPMC) gels.\n                    <jats:italic>In vitro<\/jats:italic>\n                    release studies using a permeable insert system were used to compare release profiles of Withaferin-A from liposomal gels. Cytotoxicity was assessed via XTT assay on human umbilical vein endothelial cells (HUVEC) and human dermal fibroblasts (HDFa). Inflammation was induced with tumour necrosis factor-alpha (TNF-\u03b1), and anti-inflammatory effects measured using enzyme-linked immunosorbent assays for interleukin-6 (IL-6) and matrix metalloproteinase-9 (MMP9). Reactive oxygen species (ROS) levels were quantified using the DCFDA assay. Cytotoxicity studies using the XTT assay on HUVEC and HDFa cells revealed good biocompatibility at lower Withaferin-A concentrations (0\u20131\u00a0\u00b5M), though reduced viability was observed at 5\u00a0\u00b5M.\n                    <jats:italic>In vitro<\/jats:italic>\n                    release studies revealed sustained release of Withaferin-A from liposomal gels, with significantly slower release over 6\u00a0h compared to solution at 99.53% \u00b1 3.47% and 48.87% \u00b1 4.51% respectively. Anti-inflammatory effects were evaluated following TNF-\u03b1-induced inflammation, with Withaferin-A loaded gels significantly reducing IL-6 secretion in a dose-dependent manner in both HUVECs (38.90 \u00b1 5.34 to 19.15 \u00b1 3.56\u00a0pg\/mL) and HDFa cells (40.05 \u00b1 2.23 to 10.42 \u00b1 2.02\u00a0pg\/mL). Withaferin-A treatment also reduced ROS levels and lowered MMP-9 secretion in HDFa cells from 408.80 \u00b1 13.05\u00a0pg\/mL to 195.00 \u00b1 7.55\u00a0pg\/mL, indicating potential for tissue remodelling. In summary, WA-loaded liposomal gels demonstrated effective anti-inflammatory activity and sustained drug release while maintaining biocompatibility at therapeutic concentrations. These findings support their potential as a novel strategy for managing inflammatory skin diseases by improving drug bioavailability and promoting tissue repair.\n                  <\/jats:p>","DOI":"10.3389\/bjbs.2025.14847","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:10:24Z","timestamp":1764569424000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Formulation and In Vitro Characterisation of Withaferin A-Loaded Liposomal Gels for the Topical Management of Chronic Inflammatory Skin Conditions"],"prefix":"10.3389","volume":"82","author":[{"given":"Mandeep Kaur","family":"Marwah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan Singh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukta Sameer","family":"Hindalekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Kainth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmida","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21315\/mjms2023.30.1.2","article-title":"Reactive Oxygen Species and Antioxidant System in Selected Skin Disorders","volume":"30","author":"Md Jaffri","year":"2023","journal-title":"Malays J Med Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/jpm12091370","article-title":"Skin Inflammation-A Cornerstone in Dermatological Conditions","volume":"12","author":"Tampa","year":"2022","journal-title":"J Pers Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.24976\/Discov.Med.202436189.180","article-title":"The Pathophysiology, Diagnosis and Management of Chronic Inflammatory Skin Diseases","volume":"36","author":"Tong","year":"2024","journal-title":"Discov Medicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse Effects of Topical Glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/1346-8138.14338","article-title":"Asian Consensus on Assessment and Management of Mild to Moderate Plaque Psoriasis With Topical Therapy","volume":"45","author":"Imafuku","year":"2018","journal-title":"The J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1216321","DOI":"10.3389\/fimmu.2023.1216321","article-title":"Exploring the Contribution of Pro-Inflammatory Cytokines to Impaired Wound Healing in Diabetes","volume":"14","author":"Nirenjen","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1111\/1556-4029.12831","article-title":"Forensic Potential of MMPs and CC Chemokines for Wound Age Determination","volume":"60","author":"Wang","year":"2015","journal-title":"J Forensic Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9126","DOI":"10.3390\/ijms14059126","article-title":"Targeting the Redox Balance in Inflammatory Skin Conditions","volume":"14","author":"Wagener","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/masy.200900028","article-title":"Polymer\u2010Based Biomaterials as Dressings for Chronic Stagnating Wounds","volume":"294","author":"Wiegand","year":"2010","journal-title":"Macromolecular Symposia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.30848\/pjb2023-4(36)","article-title":"Antinociceptive, Anti-Inflammatory, and Antioxidant Studies on Withania somnifera (L.) Dunal","volume":"55","author":"Baghalpour","year":"2023","journal-title":"J Pak J Bot"},{"key":"B11","doi-asserted-by":"publisher","first-page":"27236","DOI":"10.1038\/srep27236","article-title":"Withaferin A Protects Against Palmitic Acid-Induced Endothelial Insulin Resistance and Dysfunction Through Suppression of Oxidative Stress and Inflammation","volume":"6","author":"Batumalaie","year":"2016","journal-title":"Scientific Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12010-018-2920-2","article-title":"Withaferin A Protects Against High-Fat Diet\u2013Induced Obesity via Attenuation of Oxidative Stress, Inflammation, and Insulin Resistance","volume":"188","author":"Abu Bakar","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/pca.2968","article-title":"Preparation of Withaferin A Nanoparticles Extracted from by the Expansion of Supercritical Fluid Solution","volume":"31","author":"Karimi","year":"2020","journal-title":"Phytochem Anal"},{"key":"B14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11095-021-03164-z","article-title":"Transdermal Delivery of a Hydrogen Sulphide Donor, ADT-OH Using Aqueous Gel Formulations for the Treatment of Impaired Vascular Function: An Ex Vivo Study","volume":"39","author":"Marwah","year":"2022","journal-title":"Pharm Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/08982104.2019.1604746","article-title":"Intracellular Uptake of EGCG-Loaded Deformable Controlled Release Liposomes for Skin Cancer","volume":"30","author":"Marwah","year":"2020","journal-title":"J Liposome Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/08982104.2021.1956529","article-title":"Development of a Novel Polymer-Based Carrier for Deformable Liposomes for the Controlled Dermal Delivery of Naringenin","volume":"32","author":"Marwah","year":"2022","journal-title":"J Liposome Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/jfb9010013","article-title":"Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications","volume":"9","author":"Larra\u00f1eta","year":"2018","journal-title":"J Functional Biomaterials"},{"key":"B18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-3-662-45013-0_23","article-title":"Liposomal Gels in Enhancing Skin Delivery of Drugs","volume-title":"Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Drug Manipulation Strategies and Vehicle Effects","author":"Tavano","year":"2015"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/0005-2736(73)90408-2","article-title":"Single Bilayer Liposomes Prepared Without Sonication","volume":"298","author":"Batzri","year":"1973","journal-title":"J Biochim Biophys Acta -Biomembranes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2147\/DDDT.S507697","article-title":"Novel AP39-Loaded Liposomes Sustain the Release of Hydrogen Sulphide, Enhance Blood-Brain Barrier Permeation, and Abrogate Oxidative Stress-Induced Mitochondrial Dysfunction in Brain Cells","volume":"19","author":"Al Tahan","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"112335","DOI":"10.1016\/j.msec.2021.112335","article-title":"Preparation and Characterization of Withaferin A Loaded Pegylated Nanoliposomal Formulation with High Loading Efficacy: In Vitro and In Vivo Anti-Tumour Study","volume":"128","author":"Abeesh","year":"2021","journal-title":"Mater Sci Eng C"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.17504\/protocols.io.dm6gpjyx1gzp\/v2","article-title":"Liposome Synthesis Protocol: Synthesis of Cationic Liposome Nanoparticles Using a Thin Film Dispersed Hydration and Extrusion Method. V2","author":"Carroll","year":"2023","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/08982100802129372","article-title":"Influence of Drug-to-Lipid Ratio on Drug Release Properties and Liposome Integrity in Liposomal Doxorubicin Formulations","volume":"18","author":"Johnston","year":"2008","journal-title":"J Liposome Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0378-5173(02)00221-1","article-title":"Release Profile of Lidocaine HCl from Topical Liposomal Gel Formulation","volume":"242","author":"Glavas-Dodov","year":"2002","journal-title":"Int J Pharm"},{"key":"B25","doi-asserted-by":"publisher","first-page":"152474","DOI":"10.1155\/2011\/152474","article-title":"Liposomal Antioxidants for Protection Against Oxidant-Induced Damage","volume":"2011","author":"Suntres","year":"2011","journal-title":"J Toxicol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1186\/ar4064","article-title":"Prothrombotic Effects of Tumor Necrosis Factor Alpha In Vivo Are Amplified by the Absence of TNF-Alpha Receptor Subtype 1 and Require TNF-Alpha Receptor Subtype 2","volume":"14","author":"Pircher","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1165\/rcmb.2004-0288OC","article-title":"Tumor Necrosis Factor-Alpha Induces Transforming Growth Factor-Beta1 Expression in Lung Fibroblasts Through the Extracellular Signal-Regulated Kinase Pathway","volume":"32","author":"Sullivan","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3892\/or.2013.2487","article-title":"Withaferin A Inhibits Matrix Metalloproteinase-9 Activity by Suppressing the Akt Signaling Pathway","volume":"30","author":"Lee","year":"2013","journal-title":"Oncol Rep"}],"container-title":["British Journal of Biomedical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2025.14847\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:10:25Z","timestamp":1764569425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2025.14847\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":28,"alternative-id":["10.3389\/bjbs.2025.14847"],"URL":"https:\/\/doi.org\/10.3389\/bjbs.2025.14847","relation":{},"ISSN":["2474-0896"],"issn-type":[{"value":"2474-0896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"14847"}}